Results 231 to 240 of about 1,073,278 (354)

CLDN18.2 CAR‐derived Extracellular Vesicle Immunotherapy Improves Outcome in Murine Pancreatic Cancer

open access: yesAdvanced Healthcare Materials, EarlyView.
CLDN18.2 CAR‐T cell‐derived small extracellular vesicles (CAR‐sEVs) display potent cytotoxicity and prolong survival in preclinical pancreatic cancer models. They contain functional CAR proteins and granzyme B, exhibit antigen specificity, and effectively target tumor cells while sparing healthy cells.
Yue Qing   +7 more
wiley   +1 more source

Dendrimer Conjugates with PD‐L1‐Binding Peptides Enhance In Vivo Antitumor Immune Response

open access: yesAdvanced Healthcare Materials, EarlyView.
In this paper, a novel nanoparticle scaffold composed of dendrimers conjugated with peptide‐based immune checkpoint inhibitors, enhancing drug delivery efficacy is introduced. By conjugating PD‐L1‐binding peptides to dendrimers, multivalent binding effects are harnessed, resulting in enhanced binding affinity, prolonged half‐life, and improved ...
DaWon Kim   +11 more
wiley   +1 more source

Femtosecond laser microfabrication of a fully-integrated optofluidic device for 3D imaging flow cytometry. [PDF]

open access: yesSci Rep
Sala F   +6 more
europepmc   +1 more source

SPURIOUS LYMPHOCYTE PHENOTYPES BY FLOW CYTOMETRY FROM MONONUCLEAR CELLS PREPARED BY FICOLL-HYPAQUE [PDF]

open access: bronze, 1987
Herbert B. Slade   +5 more
openalex   +1 more source

Geometric Adjustment of T Cell‐Sensitive Nanorobots for Enhanced Stability

open access: yesAdvanced Healthcare Materials, EarlyView.
For the long‐term use of live dendritic cell (DC)‐based vaccines, nano bone marrow dendritic cell (BMDC) originated T cell activators (nano‐BOTs) are synthesized. The geometric properties of nanoparticles are precisely modulated, enhancing their stability and T cell activation capacity.
Yoojin Lee   +11 more
wiley   +1 more source

The Power of Reagent Titration in Flow Cytometry. [PDF]

open access: yesCells
Bonilla DL   +4 more
europepmc   +1 more source

Immunosuppressive Cytokine‐Tethered Hydrogel for Treating Rheumatoid Arthritis

open access: yesAdvanced Healthcare Materials, EarlyView.
An injectable hydrogel is developed by chemically tethering IL‐4, an immunosuppressive cytokine, to a hyaluronic acid‐based backbone. The hydrogel reduces joint friction and exerts immunomodulatory effects. In a rheumatoid arthritis (RA) mouse model, it reduced inflammation, preserved cartilage, and promoted anti‐inflammatory immune responses.
Woojin Back   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy